Cetrorelix Acetate Kit
Product Images NDC 65219-292
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Cetrorelix Acetate (NDC 65219-292). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fresnius Kabi Logo (Cet05 0000 02)
Cetrorelix-spl-fig.1 (Cet05 0000 03)
Cetrorelix-spl-fig.2 (Cet05 0000 04)
Cetrorelix-spl-fig.3 (Cet05 0000 05)
Cetrorelix-spl-fig.4 (Cet05 0000 06)
Cetrorelix-spl-fig.5 (Cet05 0000 07)
Cetrorelix-spl-fig.6 (Cet05 0000 08)
Cetrorelix-spl-fig.7 (Cet05 0000 09)
Cetrorelix-spl-fig.8 (Cet05 0000 10)
Cetrorelix-spl-fig.9 (Cet05 0000 11)
10 (Cet05 0000 12)
Cetrorelix-spl-fig.11 (Cet05 0000 13)
Package Label (PRINCIPAL DISPLAY – Cetrorelix Acetate Single-Dose Vial Label)
This is product information for a subcutaneous injection indicated for medical use. It is a sterile solution contained in a single-dose vial. The vial should be protected from light and stored refrigerated between 2-8°C. The product contains Cetrorelix Acetate for Injection at a strength of 0.25 mg per vial. The manufacturer is Fresenius Kabi based in Lake Zurich, IL.*
Pdp Info – Cetrorelix Acetate For Injection 286701 Pfs (Cet05 0000 15)
Package Label (PRINCIPAL DISPLAY – Cetrorelix Acetate Blister Foil Label)
This text provides information about Cetrorelix Acetate for injection, with details on its packaging (single-dose vial, pre-filled syringe, needles), storage instructions (refrigerated), and proper usage (subcutaneous use only). The manufacturer is Fresenius Kabi. The product has a strength of 5 mg/vial and 0.25 mg/vial. Additional details include lot numbers and expiration dates for tracking purposes.*
Package Label (PRINCIPAL DISPLAY)
This is a description of Cetrorelix Acetate for Injection, a medication in vial form containing 0.25 mg of cetrorelix acetate. Each vial also includes 54.8 mg of mannitol. The package includes one pre-filled syringe with diluent for reconstitution. It is intended for subcutaneous use only and must be stored refrigerated at 2-8°C. The medication should be used immediately after reconstitution and kept out of reach of children. Information on dosage and potential side effects is available in the package insert. Report any side effects to FDA at 1-800-FDA-1088.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.